Founded in 1781 as a market stall in Osaka, Japan. Global Headquarters in Tokyo, Japan. Global Hub in Cambridge, Massachusetts.

We do business with purpose, with approximately 50,000 employees. Revenue of approximately $30.3 billion.

Redefining the industry across 25+ manufacturing sites and 3 research sites. We have a presence in approximately 80 countries and regions. Top employer in 39 countries and 4 regions.

We follow the science & aim to unlock innovation. Whether we are developing a therapy in one of our labs or through more than 200 R&D partnerships, with an R&D investment of $4.8 billion in fiscal year 2022.

In our areas of focus: Gastrointestinal and inflammation, rare diseases, plasma-derived therapies, oncology, neuroscience, vaccines.

We aim to unlock innovation so that we can transform more lives.

Better Health, Brighter Future

All numbers as of June 2023 unless otherwise noted.
© 2023 Takeda Pharmaceutical Company Limited. All rights reserved.